GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neuroscientific Biopharmaceuticals Ltd (ASX:NSB) » Definitions » Net Margin %

Neuroscientific Biopharmaceuticals (ASX:NSB) Net Margin %

: 0.00% (As of Dec. 2023)
View and export this data going back to 2018. Start your Free Trial

Net margin is calculated as Net Income divided by its Revenue. Neuroscientific Biopharmaceuticals's Net Income for the six months ended in Dec. 2023 was A$-1.23 Mil. Neuroscientific Biopharmaceuticals's Revenue for the six months ended in Dec. 2023 was A$0.00 Mil. Therefore, Neuroscientific Biopharmaceuticals's net margin for the quarter that ended in Dec. 2023 was 0.00%.

The historical rank and industry rank for Neuroscientific Biopharmaceuticals's Net Margin % or its related term are showing as below:


ASX:NSB's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -163.32
* Ranked among companies with meaningful Net Margin % only.

Neuroscientific Biopharmaceuticals Net Margin % Historical Data

The historical data trend for Neuroscientific Biopharmaceuticals's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuroscientific Biopharmaceuticals Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23
Net Margin %
- - - - -

Neuroscientific Biopharmaceuticals Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Margin % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -264.02 - -

Competitive Comparison

For the Biotechnology subindustry, Neuroscientific Biopharmaceuticals's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neuroscientific Biopharmaceuticals Net Margin % Distribution

For the Biotechnology industry and Healthcare sector, Neuroscientific Biopharmaceuticals's Net Margin % distribution charts can be found below:

* The bar in red indicates where Neuroscientific Biopharmaceuticals's Net Margin % falls into.



Neuroscientific Biopharmaceuticals Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Neuroscientific Biopharmaceuticals's Net Margin for the fiscal year that ended in Jun. 2023 is calculated as

Net Margin=Net Income (A: Jun. 2023 )/Revenue (A: Jun. 2023 )
=-1.069/0
= %

Neuroscientific Biopharmaceuticals's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-1.23/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neuroscientific Biopharmaceuticals  (ASX:NSB) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Neuroscientific Biopharmaceuticals Net Margin % Related Terms

Thank you for viewing the detailed overview of Neuroscientific Biopharmaceuticals's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Neuroscientific Biopharmaceuticals (ASX:NSB) Business Description

Traded in Other Exchanges
N/A
Address
85 Forrest Street, Suite 5, Cottesloe, Perth, WA, AUS, 6011
Neuroscientific Biopharmaceuticals Ltd is an Australian-based biotechnology company. The company is engaged in the development of diagnostic and therapeutic treatments for neurodegenerative diseases through preclinical studies of patented technologies.

Neuroscientific Biopharmaceuticals (ASX:NSB) Headlines

No Headlines